Impact of electric cardioversion on platelet activatio

• Conditions: I48.0; Paroxysmal atrial fibrillation

• Registration Number: DRKS00019949
• Lead Sponsor: Medizinische Universität Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-04-08
• Study Start: 2019-12-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Atrial fibrillation

Exclusion Criteria

anti platelet drugs

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PAC-1 (platelet surface marker) measured with FACS

Secondary Outcome Measures

Name	Time	Method
p-Selektin (platelet surface marker) <br>Parameter of platelet aggregation measurement (AUC)